Daily Derm Times: June 3, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Adam Friedman, MD, FAAD: Spotlighting Disparities in Lichen Planus Screening and Treatment

Friedman discusses survey findings revealing inconsistent screening, outdated assumptions, and lack of FDA-approved therapies for lichen planus.

Fall Clinical Dermatology Conference for PAs and NPs 2025 Recap

Explore cutting-edge insights and networking opportunities at the Fall Clinical PA/NP Conference, focusing on dermatology education and innovative treatments.

Atopic Dermatitis Associated With Higher Dementia Risk

Through a comprehensive review and meta-analysis, researchers identified the correlation between atopic dermatitis and dementia.

Arcutis’ Roflumilast Becomes First FDA-approved Treatment to Receive the NPF’s Seal of Recognition

The National Psoriasis Foundation Seal of Recognition program has expanded to prescription drugs, making roflumilast the first to achieve the indication.

Road to RAD: The Ins and Outs of Managing CHE

Jonathan Silverberg, MD, PhD, MPH, emphasizes the importance of accurately identifying the underlying etiology of chronic hand eczema.

Visible Light Protection: Needs and Strategies for Diverse Patients

New research highlights the importance of tinted sunscreens with iron oxides for effective protection against visible light-induced skin pigmentation, especially for darker skin tones.